Persist AI
Developing long-lasting drug formulations 50% faster
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
It takes 5 years for pharma to develop long lasting drug injections for chronic diseases like cancer and diabetes. Persist uses AI-driven automation to reduce formulation development time down to 2 years, a ~50% reduction. Persist AI is a Y Combinator company (Winter 2023). YC-listed status: Active.
- Website
- persist.ai
- Location
- Sacramento, CA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Persist AI — Fee-for-service pharmaceutical formulation AI that uses robotics and AI models to develop drug formulations faster than industry standards. · Service
Links
- Y Combinator profileycombinator